Top 50 Health Care VC Funds & Investors in Finland (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Business Finland
VC Fund
|
20 | Finland, United States, United Kingdom | Grant, Seed, Debt Financing | Software, Biotechnology, SaaS | $53k–$10M |
|
Butterfly Ventures
VC Fund
|
16 | Finland, Sweden, Norway | Seed, Pre-Seed | Health Care, Software, Information Technology | $110k–$4.3M |
|
Lifeline Ventures
VC Fund
|
16 | Finland, United States, United Kingdom | Seed, Series A | Software, Health Care, E-Commerce | $547k–$20M |
|
Finnvera Venture Capital
VC Fund
|
15 | Finland, United States, Chile | Seed, Series A | Software, Health Care, Information Technology | $250k–$22M |
|
Voima Ventures
VC Fund
|
13 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $439k–$30M |
|
Icebreaker.vc
VC Fund
|
12 | Finland, Sweden, Estonia | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $106k–$25M |
|
Tesi
VC Fund
|
12 | Finland, United States, Switzerland | Series A, Series B | Software, Manufacturing, Health Care | $2.2M–$41M |
|
Innovestor
VC Fund
|
11 | Finland, Sweden, Denmark | Seed, Pre-Seed | Software, Health Care, Information Technology | $204k–$4.5M |
|
Springvest
VC Fund
|
8 | Finland | Series A, Seed | Biotechnology, Health Care, Energy | $1.6M–$53M |
|
Redstone.VC
VC Fund
|
7 | Germany, Finland, Switzerland | Seed, Series A, Pre-Seed | Software, Information Technology, Health Care | $505k–$17M |
|
Nordic Science Investments
VC Fund
|
6 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$4.6M |
|
Visionplus
VC Fund
|
5 | Finland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Internet | $77k–$14M |
|
Inventure
VC Fund
|
5 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$25M |
|
Reaktor Ventures
VC Fund
|
5 | Finland, Germany, United States | Seed, Pre-Seed, Series A | Internet, Software, E-Commerce | $137k–$6.6M |
|
Antler
VC Fund
|
4 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $108k–$28M |
|
Almaral
VC Fund
|
4 | Finland | Seed, Convertible Note | Medical Device, Health Diagnostics, Software | $1.1M–$2.9M |
|
University of Helsinki
VC Fund
|
4 | Finland, Luxembourg, United States | Seed, Pre-Seed, Series A | Medical, Health Care, Biotechnology | $54k–$7.4M |
|
Superhero Capital
VC Fund
|
4 | Finland, Lithuania, Estonia | Seed, Pre-Seed, Series A | Software, Information Technology, Internet | $212k–$8.2M |
|
Maki.vc
VC Fund
|
4 | Finland, Norway, Denmark | Seed, Series A, Pre-Seed | Software, E-Commerce, Information Technology | $900k–$37M |
|
VTT Ventures
VC Fund
|
4 | Finland | Seed, Series A | Biotechnology, Manufacturing, Sensor | $460k–$13M |
|
Oy Hammaren & Co Ab
VC Fund
|
3 | Finland | Angel, Series A | Health Care, Wellness, GreenTech | |
|
Nidoco
VC Fund
|
3 | Finland, Sweden, Estonia | Seed, Series A | Software, Health Care, Apps | $327k–$2.7M |
|
Nostetta Ventures
VC Fund
|
3 | Finland | Seed, Pre-Seed | Health Care, Medical Device | $1.1M–$2.9M |
|
Cor Group
VC Fund
|
3 | Finland | Seed, Pre-Seed, Series A | Health Care, Medical, Biotechnology | $2.4M–$8.7M |
|
Sitra
VC Fund
|
3 | Finland, The Netherlands | Series A, Series C | Health Care, Biotechnology, Therapeutics | |
|
Lynx Capital
VC Fund
|
3 | Finland | Series A, Seed | Health Care, Medical, Therapeutics | |
|
Athensmed
VC Fund
|
3 | Finland | Seed, Series A | Health Care, Medical, mHealth | $1.1M–$1.3M |
|
M Ventures
VC Fund
|
3 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | |
|
EQT Life Sciences
VC Fund
|
2 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.9M–$165M |
|
Metsola Ventures
VC Fund
|
2 | Finland | Series A | Medical, mHealth, Health Care | $2.2M–$4.8M |
|
Karolinska
VC Fund
|
2 | Sweden, Denmark, United States | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $1.3M–$73M |
|
Gorilla Capital
VC Fund
|
2 | Finland, Sweden, Estonia | Pre-Seed, Seed, Series A | Software, SaaS, Information Technology | $149k–$5M |
|
Sofinnova Partners
VC Fund
|
2 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
|
Kinled Holding
VC Fund
|
2 | United Kingdom, United States, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $500k–$43M |
|
Novartis Venture Fund
VC Fund
|
2 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$120M |
|
Nina Capital
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $573k–$21M |
|
Stephen Industries
VC Fund
|
2 | Finland, Sweden | Seed, Series A, Pre-Seed | Software, Health Care, Biotechnology | $330k–$45M |
|
Illusian Founder Office
VC Fund
|
2 | Finland, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $2.6M–$90M |
|
Alliance VC
VC Fund
|
2 | Norway, United States, Sweden | Seed, Series A, Pre-Seed | Software, Information Technology, Analytics | $1M–$19M |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$92M |
|
Korpun Siemen
VC Fund
|
2 | Finland | Seed, Angel | Software, Marketing, Information Technology | $480k–$1.3M |
|
Cascara Ventures
VC Fund
|
2 | Germany, Finland, The Netherlands | Series A, Seed, Series B | Medical, Health Care, Biotechnology | |
|
Samsung Venture Investment
VC Fund
|
2 | South Korea, United States, India | Series A, Series B, Seed | Information Technology, Software, Health Care | $45k–$28M |
|
Heino Group
VC Fund
|
2 | Finland | Seed, Angel, Pre-Seed | B2B, Fruit, Gaming | $384k–$1.9M |
|
Pontos Group
VC Fund
|
2 | Finland | Genetics, Hospital, Automotive | ||
|
Vesalius Biocapital Partners
VC Fund
|
2 | Belgium, Germany, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | |
|
Novo Holdings
VC Fund
|
2 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | |
|
European Investment Bank
VC Fund
|
2 | Germany, France, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | |
|
Tradeka
VC Fund
|
2 | Finland | Angel, Pre-Seed | Fruit, Gaming, Nutrition | |
|
Broadview Ventures
VC Fund
|
2 | United States, Israel, Denmark | Series A, Seed, Debt Financing | Health Care, Biotechnology, Medical Device | |
| Access all 262 VC funds in Finland Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Grant, Seed, Debt Financing
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 219
- Round size: Seed $297k–$3.5M; Grant $53k–$10M; Debt Financing $241k–$6.7M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- eMabler — EMabler is an EV charging infrastructure software company that develops an API-first platform used by businesses to operate, manage, and scale electric vehicle charging networks. It provides a centralized system for charge point management, billing, pricing, roaming, and energy optimization, allowing operators to control large networks of EVchargers from a single platform. The software connects charging hardware with business systems such as CRM, payment, and energy management tools through open APIs and a large library of integrations. The company focuses on enabling enterprises, such as energy utilities, parking operators, and retail businesses, to embed EV charging directly into their existing services and digital platforms rather than building standalone charging systems. This includes white-label solutions where charging is integrated into a company’s own app or customer experience under its brand.
- Coolbrook — Coolbrook is a manufacturer of naphtha cracking-based reactors. Their technology is intended to replace the conventional steam cracker furnace in existing and new olefins plants, enabling petrochemical clients to get improved product yield and lower energy consumption.
- Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 87
- Round size: Seed $373k–$2.1M; Pre-Seed $110k–$4.3M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
- CooliBlade — Superior power electronics cooling solutions for applications like solar and wind energy, energy storage, EV charging and telecommunications.
- Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 190
- Round size: Seed $547k–$5.4M; Series A $2.7M–$20M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $171M in 2023
Portfolio highlights
- ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
- Thor Dynamics — Headquartered in Orlando, Florida, with a European base in Finland, Thor Dynamics specializes in directed energy systems for defense against drones and drone swarms. The company’s innovative solutions are available worldwide to protect critical infrastructure and enhance national security. Laser Armor™ is a complete directed energy counter-dronesolution. Utilizing advanced radar and optical systems it can detect, track, and target hostile targets. High-power directed energy from Thor’s Laser Engines then eliminates the threat in seconds. Multiple safety systems ensure accurate target identification and minimal collateral damage.
- Everywear Games — Metacore is a wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s games are consistently on top ofglobal charts.
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Finland, United States, Chile
Investor stats
- Total investments: 95
- Round size: Seed $250k–$2.3M; Series A $1.7M–$22M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
- eMabler — EMabler is an EV charging infrastructure software company that develops an API-first platform used by businesses to operate, manage, and scale electric vehicle charging networks. It provides a centralized system for charge point management, billing, pricing, roaming, and energy optimization, allowing operators to control large networks of EVchargers from a single platform. The software connects charging hardware with business systems such as CRM, payment, and energy management tools through open APIs and a large library of integrations. The company focuses on enabling enterprises, such as energy utilities, parking operators, and retail businesses, to embed EV charging directly into their existing services and digital platforms rather than building standalone charging systems. This includes white-label solutions where charging is integrated into a company’s own app or customer experience under its brand.
- CHAOS — CHAOS is an urban forecasting company for real estate investors and city developers. Our AI platform processes urban data and crowd insights to forecast investment and development for creating liveable cities.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 59
- Round size: Seed $1M–$5.9M; Pre-Seed $439k–$2.1M; Series A $3.9M–$30M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- Nucu — The Nucu Pad is a multisensory baby pad that soothes your baby to sleep with womb-like feelscapes.
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Sofi Filtration — Innovation in Industrial Liquid Filtration
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 124
- Round size: Seed $384k–$5.2M; Pre-Seed $106k–$1.3M; Series A $3.1M–$25M
- Lead/follow: 53% lead, 47% follow
- Last fund: May invest from a new fund soon — raised $22M in 2021
Portfolio highlights
- Cytely — Transforms microscopy from image-driven to data-driven through AI-powered autonomous targeting that captures high-resolution data of critical cellular events, enabling researchers to solve complex biological problems in minutes instead of years.
- Oplane — Oplane AB is a cybersecurity startup that develops an AI powered platform for automated threat modeling for software development teams.
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Series A, Series B
- Geography: Finland, United States, Switzerland
Investor stats
- Total investments: 145
- Round size: Series A $2.2M–$41M; Series B $3.1M–$35M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
- Vexlum —
- Wirepas — Wirepas offers a standards-based, ultra-reliable mesh connectivity for infrastructure-grade IoT. Proven in millions of devices worldwide.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 87
- Round size: Seed $478k–$4.5M; Pre-Seed $204k–$2M
- Lead/follow: 59% lead, 41% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Jaakko.com — Reinventing the housing market with no agents, more homes, and less fees.
- Retailgrid — Retailgrid is an AI-powered retail workspace that enables pricing, merchandising, and commercial teams to analyze data, run simulations, and make decisions in real time. Combining a flexible spreadsheet-like interface with AI agents, RetailGrid replaces fragmented tools and manual workflows with a single system for pricing optimization, promotionplanning, and assortment decisions. The platform connects to product, sales, and competitor data, automatically generates insights, and allows teams to test scenarios and deploy decisions at scale. RetailGrid is built for data-driven retailers looking to move faster and operate with the efficiency of top-tier consulting, without the cost or complexity.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Series A, Seed
- Geography: Finland
Investor stats
- Total investments: 23
- Round size: Seed $1.6M–$7.6M; Series A $3.6M–$53M
- Lead/follow: 74% lead, 26% follow
Portfolio highlights
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- MedicubeX — MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Finland, Switzerland
Investor stats
- Total investments: 174
- Round size: Seed $505k–$8M; Pre-Seed $1M–$4.4M; Series A $1.6M–$17M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $57M in 2023
Portfolio highlights
- Nomerra — Nomerra operates a business-to-business software-as-a-service model providing an AI-native operating platform tailored for enterprise asset servicers and private market asset managers. The company’s core value proposition focuses on automating fragmented, document-heavy back-office workflows across fund accounting, treasury management, and transferagency functions by deploying specialized AI agents that integrate directly with existing ERPs, banking networks, and email systems. These autonomous agents execute end-to-end operational tasks and validate data while providing human teams with full audit trails, effectively shifting human responsibilities from manual data compilation to automated output review.
- Talentir — Content Monetization
- Waniwani — WaniWani develops AI infrastructure that helps companies distribute products and services through AI platforms such as ChatGPT, Claude, and Gemini. It enables AI storefronts, customer discovery, quoting workflows, analytics, and compliance monitoring for businesses using conversational AI channels.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 17
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
- Lead/follow: 88% lead, 12% follow
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — Mu-ray.tech is focused on advancing the field of medical diagnostics and industrial quality control. mu-ray.tech is developing a groundbreaking technology for the rapid, safe and accurate 3D-imaging of the chemical composition of scanned objects, serving critical needs in industrial quality control and medical diagnostics. The technology is basedon Muon Beam Imaging (MBI), an innovative technology leveraging Laser Plasma Accelerator-based artificial muon sources, new generation particle detector systems and AI. In industry, we are working with the partners in the heavy, aerospace, and defence domains.mu-ray.tech operates at the three sites: DESY in Hamburg (hardware), Tehnopol in Tallinn (algorithms and software), and Bradfield Centre in Cambridge (algorithms, business development). Our main collaboration on the MBI technology partners are GScan in Estonia and UK, DESY in Hamburg, the University of Cambridge, and KBFI in Tallinn.
- Perfat Technologies — Perfat Technologies is a health-based technology company that develops fat-management applications based on healthy vegetable oils.
WE HELP YOU TO GROW FASTER!
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 74
- Round size: Seed $77k–$1.3M; Series A $2M–$14M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Gizlo — We provide a platform for businesses to connect and collaborate with mobile users around the world, gaining valuable insights and opinions, which matter more than ever.
- Enreach — ZEUS99 Situs Slot Game Resmi Perpaduan Game Demo Wild Bandito Game Online Bertemakan Koboi Barat Dengan Banyak Bonus Menarik Yang Tersedia Di PG Soft Terpercaya
- Film Finances — Discover Film Finances Inc., the global leader in film completion guarantees, ensuring on-schedule and on-budget delivery for over seven decades. Explore our services and industry expertise.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 172
- Round size: Seed $549k–$5.9M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Finch — Optimize building design with AI and graph technology. Get immediate feedback on performance, detect errors and find optimal solutions.
- ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
- Valuebeat — Grow your culture. Backed by data. Platypus is the HR and recruitment tool that measures cultural drivers of people across the organization to help you qualify decisions on hiring and managing your culture.
Reaktor Ventures they invest in seed stage companies and helps them to create markets.
Show more...Investment focus
- Industry: Internet, Software, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Germany, United States
Investor stats
- Total investments: 55
- Round size: Seed $137k–$2M; Pre-Seed $159k–$1.8M; Series A $1.7M–$6.6M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
- Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
- allies.digital — Allies is a match-making platform curating businesses with IT-, digital and creative agencies. No more miss-matches when buying IT & creative services.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 1820
- Round size: Seed $186k–$4.6M; Pre-Seed $108k–$750k; Series A $4.6M–$28M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fresh fund, raised $72M in 2024
Portfolio highlights
- Agentio — Agentio's patent-pending ad platform empowers marketers to finally unlock scalable, creator-led advertising. Programmatically buy the highest quality creator and influencer ad reads to deliver unprecedented efficiency and performance.
- Codis.io — COD LEGAL BLOG CONTACT US Areas We Serve California Florida TEXAS Ohio Trusted Insights on Birth Injury and Medical Negligence Law COD LEGAL BLOG is a dedicated legal information platform created to help readers understand complex legal matters in a clear and structured way. Click here to learn more. The legal system can often feel
- Quantflo — Options market intelligence and structured trade planning for Indian markets.
Almaral provides risk management advice long-term strategy development budgeting operational function setup legal support early-stage sales and marketing function setup, and commercialization.
Show more...Investment focus
- Industry: Medical Device, Health Diagnostics, Software
- Stage:Seed, Convertible Note
- Geography: Finland
Investor stats
- Total investments: 5
- Round size: Seed $1.1M–$2.9M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Fepod — Fepod Oy Ltd develops a point-of-care diagnostics platform for rapid blood concentration measurement of pain medicine and other markers. Using a mobile phone, portable reader, and disposable sensors, it delivers quick, accurate results in minutes, enabling timely treatment decisions in acute care settings. The company aims to be the #1 acute carePOC diagnostics platform by 2030.
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The Universityconcentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Luxembourg, United States
Investor stats
- Total investments: 11
- Round size: Seed $54k–$7.4M; Pre-Seed $837k–$1.2M; Series A $2.9M–$3.9M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Ferrivia — Ferrivia Oy is a Finnish health-tech startup specializes in digital health services and personalized tracking for iron deficiency and low ferritin levels.
- MultivisionDx — MultivisionDx's computer vision technology integrates the tumor's unique biological and geographical properties, as well as its milieu, to generate patient-specific tumor profiles.
- Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
Some call you founders. We call you Superheroes. Seed stage VC investing in insight-driven startups in Finland and the Baltics. Tickets 100 K€ - 1000 K€.
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Lithuania, Estonia
Investor stats
- Total investments: 94
- Round size: Seed $212k–$3.1M; Pre-Seed $618k–$1.8M; Series A $3.4M–$8.2M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Zadaa — We are the world’s first marketplace to make selling and buying secondhand as simple as in an online store. We have revolutionised C2C logistics regarding pricing and marketplace integration between multiple logistic companies operating on different markets. Zadaa is live on German, Danish and Finnish markets.
- Creagent — Find designers. Screened & shortlisted. Easy, fast and cost-effective - the smart way of sourcing with AI.
- Pricen — Pricen is an AI-driven dynamic pricing platform for retail and e-commerce. Used in over 32 countries, Pricen helps retail and e-commerce businesses to maximize profitability with an AI-driven pricing solution that intelligently optimizes product prices at every stage, from launch to markdown. The platform integrates seamlessly with your ERP, PIMand major e-commerce ecosystems.AI-Driven Pricing Pricing Simulator Pricing Automation Pricing Management Platfom
We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention.We invest in early stage companies: fromtheir inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Norway, Denmark
Investor stats
- Total investments: 98
- Round size: Seed $900k–$8M; Pre-Seed $1.1M–$2.7M; Series A $3.3M–$37M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Disior — At Disior, we build software to measure and model tissue structures in CT- and MRI-images for better diagnosis and treatment planning.Our solutions are for clinical use. They enable fast, accurate and reproducible measuring for diagnostics and patient-specific, optimized treatment planning. Based on mathematical modelling, Disior algorithmsextract the correct shape or structure from the medical image. This way, the software is not dependent on finding familiar structures or comparing something to reference data. We combine engineering and R&D talent with medical and biotechnology professionals. Our team brings together decades of experience in creating world’s best simulation and modelling systems from smartphone R&D; clinicians and researchers in maxillofacial and orthopedics; and technology innovation and commercialization.For demo, pilots and research projects, please contact Anna-Maria Henell, CEO: +358 50 483 6433 / anna-maria (at) disior.com
- IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
- K Line Europe — Clear Aligner solutions made in Germany for dentists, orthodontists and laboratories.
VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Sensor
- Stage:Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 24
- Round size: Seed $460k–$6M; Series A $1.7M–$13M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
- Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
- Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Oy Hammaren & Co Ab provides financial services and insurance activities.
Show more...Investment focus
- Industry: Health Care, Wellness, GreenTech
- Stage:Angel, Series A
- Geography: Finland
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- Heltti — We are Heltti! We help people and knowledge workplaces feel better.
- NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
Nidoco AB is a Swedish investment company whose strategy is to create long-term value through active ownership of public and private companies.
Show more...Investment focus
- Industry: Software, Health Care, Apps
- Stage:Seed, Series A
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 25
- Round size: Seed $327k–$2.7M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Betolar — Betolar is a materials technology company that develops circular economy solutions for the mining, metals, and construction sectors by transforming industrial sidestreams and waste materials into valuable products. Its technologies support the production of low-carbon, cement-free construction materials and enable the recovery of critical andstrategic metals from industrial waste streams. The company provides material analysis, consulting, and recipe optimization services, utilizing digitalization, data platforms, and artificial intelligence to support research, development, and industrial applications. Betolar's solutions are designed to help reduce carbon emissions, decrease reliance on virgin raw materials, and improve the utilization of industrial byproducts. Its activities span construction materials, metal extraction technologies, and circular material solutions that support more resource-efficient industrial processes.
- TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
- CHAOS — CHAOS is an urban forecasting company for real estate investors and city developers. Our AI platform processes urban data and crowd insights to forecast investment and development for creating liveable cities.
Nostetta Ventures is a venture capital company investing in growth companies mainly in the North Savo region.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Finland
Investor stats
- Total investments: 3
- Round size: Seed $1.1M–$2.9M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Marginum — Pioneering the next-generation quantitative surgical techniques.
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 5
- Round size: Seed $2.4M–$8.7M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Gosta Labs — Focus on care
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Nightingale Health — The most advanced health check for the health industry.
Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Series A, Series C
- Geography: Finland, The Netherlands
Investor stats
- Total investments: 7
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- SET Ventures — SET propels founders from early growth to European scale. We invest in and grow the solutions powering the digital energy economy.
cross-border, healthcare, life science, investment, VC, China, US
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Series A, Seed
- Geography: Finland
Investor stats
- Total investments: 4
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Elucida Oncology — Elucida Oncology focuses on transforming outcomes for patients with primary solid tumors and metastatic cancer. The company utilizes the novel target or clear capabilities of its ultra-small C-Dot cancer-targeting particle platform across diagnostic imaging, surgical, and a wide range of therapeutic applications.
- Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
Athensmed Oy
Show more...Investment focus
- Industry: Health Care, Medical, mHealth
- Stage:Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 4
- Round size: Seed $1.1M–$1.3M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 145
- Lead/follow: no public data
Portfolio highlights
- IonKraft — IonKraft can provide better performance at a lower cost while maintaining recyclability, they also promote material reduction and reuse and are commercializing the technology with funding from the German Federal Ministry for Economic Affairs and Energy (BMWi).
- NovoLINC — NovoLINC is a pioneering startup that provides thermal interface solutions. It develops a distinctive system of nanostructured materials and a proprietary manufacturing process with the objective of transforming thermal management.
- TRIMTECH Therapeutics — TRIMTECH Therapeutics is a biotech organization that treats neurodegenerative illnesses by using targeted protein degradation (TPD).
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 182
- Round size: Series A $6.9M–$77M; Series B $12M–$110M; Series C $12M–$165M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $266M in 2023
Portfolio highlights
- LUMA Vision — OneProjects is an Irish-German cardiac imaging specialist.
- Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
- Rotation Medical — Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota.
Metsola Ventures
Show more...Investment focus
- Industry: Medical, mHealth, Health Care
- Stage:Series A
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Series A $2.2M–$4.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 32
- Round size: Series A $1.3M–$73M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Gorilla Capital helps ambitious startups grow with smart funding and support. Discover how our team invests in early-stage companies.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Finland, Sweden, Estonia
Investor stats
- Total investments: 66
- Round size: Seed $274k–$1.3M; Pre-Seed $149k–$680k; Series A $2.6M–$5M
- Lead/follow: 71% lead, 29% follow
Portfolio highlights
- Munchi — Munchi allows restaurants to manage all orders, payments and loyalty in one platform with the power of AI.
- Mobal — It is time to get your Business Profiles in shape. Meet your customers where they are and stand out where it matters most.
- Nordic Information Control — Inventering och klassificering av information, automatiskt med Nordic Information Control Platform. Automatic Regulatory compliance.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 319
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for thisrevolution in chemicals and biofuels.GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 133
- Round size: Seed $500k–$11M; Series A $2M–$43M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
- Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
- PreComb — PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 217
- Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
- Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 89
- Round size: Seed $2M–$6.3M; Pre-Seed $573k–$2.4M; Series A $5M–$21M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Navidence — Navidence provides a transformative Real World Evidence (RWE) Design platform that enables organizations to efficiently adapt to the ever-increasing ecosystem of Real World Data (RWD) sources. The company unlocks the power of Computable Operational Definitions (CODefs) for RWE Design and RWD Assessment. Navidence's RWE Sherpa platform offerstools to streamline the process of defining an RWE study's data, making it easier for researchers to conduct their studies in the age of data.
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
We fund futurebreakthroughs
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Sweden
Investor stats
- Total investments: 18
- Round size: Seed $482k–$8.2M; Pre-Seed $330k–$4.3M; Series A $8.3M–$45M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- AlixLabs — AlixLabs is a Swedish semiconductor startup, founded in 2019.
- Anferra — Anferra specializes in hydrometallurgy, utilizing methods for resource-efficient recycling of steel industry waste into iron chloride.
- Freepress.ai — Freepress operates with an AI-driven virtual news editor that analyzes hundreds of thousands of publicly available and licensed articles from different countries.
Illusian is the Founder Office of people who have founded and scaled companies like Supercell, Zalando, Wolt, Aiven, Pigment, and Smartly. While the group is still busy running their businesses, they've aligned their networks, capital, and expertise to simultaneously support the next generation of builders.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Finland, United States, Germany
Investor stats
- Total investments: 51
- Round size: Seed $2.6M–$9M; Series A $5.9M–$44M; Series B $35M–$90M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CodeWords —
- Riff — Databutton is an online app builder that empowers the next generation of entrepreneurs and innovators. It enables anyone to create dynamic online apps in minutes by connecting to a growing array of sources, models, and integrations, or by utilizing their own datasets. 먹튀검증 https://muktts.net/
- NewOrbit Space — NewOrbit Space is a satellite manufacturing company. We engineer Earth's lowest orbiting satellites, at altitudes of 180km (3x lower than conventional LEO satellites) we enable better imagery resolution and telecommunication services from space.
Alliance Venture is a Nordic venture capital firm investing in exceptional early-stage tech companies and purpose-driven founders with global ambitions. Offices in Oslo, Stockholm, Copenhagen and Helsinki.
Show more...Investment focus
- Industry: Software, Information Technology, Analytics
- Stage:Seed, Series A, Pre-Seed
- Geography: Norway, United States, Sweden
Investor stats
- Total investments: 83
- Round size: Seed $1.3M–$5M; Pre-Seed $1M–$4M; Series A $1.8M–$19M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Fika Jobs — is building a video-first hiring platform that combines AI interview agents with short-form video profiles.
- Newcode.ai —
- Lightbringer — Experience the future of patent services with Lightbringer. Our AI-driven platform accelerates your patent process, ensuring efficiency and expertise from world-class patent attorneys.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 130
- Round size: Series A $5.7M–$85M; Series B $12M–$92M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Korpun Siemen is backed by 33 investors who have combined their initial investment activities and have extensive experience in start-up, growth and family businesses in various industries. The company includes active angel investors, entrepreneurs in growth companies and investors who have already exited their companies.
Show more...Investment focus
- Industry: Software, Marketing, Information Technology
- Stage:Seed, Angel
- Geography: Finland
Investor stats
- Total investments: 10
- Round size: Seed $480k–$1.3M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Mobal — It is time to get your Business Profiles in shape. Meet your customers where they are and stand out where it matters most.
- Remod — Remod provides holistic IT surveys, backup services, cyber control, functional programming, data processing, incident response, secure systems, network design, and proof of concept development.
- Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.
96 Normal 0 false false false EN-GB X-NONE X-NONE
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Germany, Finland, The Netherlands
Investor stats
- Total investments: 12
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Fiagon —
- Surgify — Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa).
- SurgicEye — SurgicEye designs intra-operative imaging and instrument navigation solutions for surgical procedures. It offers a navigated radio-guided surgery based on the handheld 3-D freehand SPECT imaging technology called the declipse SPECT open surgery, an intraoperative 3D imaging system for invasive sentinel lymph node biopsy called the declipse SPECTLaparascopy, and a mobile SPECT imaging solution with a high resolution on a small footprint called the declipse SPECT imaging probe. The company also advises clients on medical device development, requirement engineering and software specification for medical devices, software development for medical devices, testing of software for medical devices, and support in the design and conduction of clinical studies.Dr. Jörg Traub founded SurgicEye in 2008, with its headquarters in Munich in Germany.
Samsung Venture Investment is plays the role of driving the discovery and development of new businesses and technologies.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, India
Investor stats
- Total investments: 134
- Round size: Seed $45k–$4.1M; Series A $1.7M–$28M; Series B $3M–$23M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- N.THING — Established in January 2014, N.THING is a Seoul-based Agri-Food tech company leading innovation in agricultural products, by extension, in the farm-to-table food value chain by combining IoT technology and data. It developed the world’s first modular vertical farm ‘CUBE’ which is easy to expand. N.THING CUBE is a modularized farm with massproductivity where a dedicated OS provides the most optimized environment for each crop so as to create maximized efficiency. N.THING is the world’s first smart farming company that won the iF Design Award, Architecture in 2020. Also, it is a winner of Best of Innovation at the CES 2020 for its excellence in technology, which is the first ever in the agricultural field. N.THING is planning to expand its business on a large scale this year after it successfully completes the PoC process in the U.A.E. Our North American branch office located in New York. N.THING hopes to connect people to nature, things to things, people to things, and people to people through IoT technologies by creating Number of Things out of Nothing. .CUBE : CUBE is internet connected modular container vertical farm. It's an ultimate indoor farm which contains LED technology, real time monitoring system through IoT sensors, collected cultivation data, and upgradable software. We deliver the farm of the desired container form to the desired place.SQUARE : SQUARE is modular hydroponic kit. SQUARE can connect each module and share water. Users can connect as many as they want, grow greens and herbs, and make food great themselves. Each Square consists of four Pickcells, which contains special nutrient-rich sponge. With special sponge and hydroponic, it gives the most simple and effective gardening experience.Planty : Planty is the first Internet-connected social pot in the world. Planty gives pleasure to grow plants with your family, friend, and colleague. Planty enables the user to monitor the environmental information on temperature, soil moisture, and ambient light around plants and give water to plants any me or anywhere.Life : Life is a smart gardening journal aimed at the gardening sector. Plant lovers and gardeners are able to record their gardening activities and information and share them through Social Media. The user can easily insert weather data, location data, gardening activities, and plants’ events. Moreover, all the gardening data can be shared through social media.Sikmulsung: Sikmulsung is our show room to explore 'freshness' of our product and service. It is a place for everyone seeking for 'freshness' in visual, in texture, in taste, in flavor or even in atmosphere with, N.THING's in-store farm, exclusively made for Sikmulsung, special F&B's and our end products.
- MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
- Aim Intelligence — Leading AI Security & Safety Solutions Provider - Specializing in AI Risk Detection, Mitigation, and Elimination through Advanced Red Teaming and Defensive Systems | Leading provider of AI Security, Safety, and Compliance solutions
Heino Group is a food and drink industry company that has grown into an active entrepreneur, investor, owner, and supporter of foodtech companies.
Show more...Investment focus
- Industry: B2B, Fruit, Gaming
- Stage:Seed, Angel, Pre-Seed
- Geography: Finland
Investor stats
- Total investments: 5
- Round size: Seed $384k–$1.9M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Vegemi — Vegemi is a free smartphone app that promotes eating fruits and vegetables through gaming. The software was designed with the entire family in mind, but especially to demonstrate youngsters the health advantages of fruits and vegetables in a way that motivates and inspires them.
- Fiberdom — Fiberdom develops sustainable materials from wood fibers, focusing on plastic-free solutions. The company offers a range of compostable cutlery designed for food service and take-away applications. These products are fully recyclable and comply with European regulations, making them suitable for environmentally conscious consumers. Fiberdomemphasizes innovation in transforming wood fibers into high-performance materials, contributing to sustainability efforts in various industries. The commitment to creating eco-friendly alternatives positions Fiberdom as a key player in the materials innovation sector.
- Arctic Farming — Disrupting food production by making vertical farming mainstream.
Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more...Investment focus
- Industry: Genetics, Hospital, Automotive
- Geography: Finland
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
- Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of €56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: Belgium, Germany, The Netherlands
Investor stats
- Total investments: 55
- Lead/follow: no public data
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 271
- Lead/follow: no public data
Portfolio highlights
- Supira Medical — Next Generation Solution for Temporary Mechanical Circulatory Support Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic shock. Clinical Need Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of
- Callio Therapeutics — Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.
- Newleos Therapeutics — Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: Germany, France, The Netherlands
Investor stats
- Total investments: 247
- Lead/follow: no public data
Portfolio highlights
- Amadix — Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide.The most advancedproduct developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients).Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
- Greenlight Biosciences — Next Generation Crop Protection
- Azienda Comprensoriale Acquedottistica — ACA Spa is an integrated water service company.
Co-operative Tradeka is a consumer co-operative involved in the restaurant business and involved in investment activities.Co-operative Tradeka is a consumer co-operative founded in the year 1917. Nowadays, the Co-operative serves approximately 225 000 members. The Co-operative Tradeka is a management co-operative, which is the owner of TradekaGroup Ltd (98%) and Tradeka-services Ltd (100%) (responsible for the membership benefits of the Co-operative). The CEO of the Co-operative Tradeka is Perttu Puro, Master of Laws.Tradeka Ltd is the sole owner of Restel Oy (involved in the restaurant business) and Tradeka-invest Ltd (involved in investment activities) The CEO Tradeka Ltd is Perttu Puro, Master of Laws.
Show more...Investment focus
- Industry: Fruit, Gaming, Nutrition
- Stage:Angel, Pre-Seed
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Vegemi — Vegemi is a free smartphone app that promotes eating fruits and vegetables through gaming. The software was designed with the entire family in mind, but especially to demonstrate youngsters the health advantages of fruits and vegetables in a way that motivates and inspires them.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Debt Financing
- Geography: United States, Israel, Denmark
Investor stats
- Total investments: 66
- Lead/follow: no public data
Portfolio highlights
- Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
- RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
- Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
Health Care VC funding in Finland at a glance
Stats across 332 deals from 262 investors.
Access all 262 VC funds in Finland Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 262 VC funds investing in Finland Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!